2Istanbul University, Istanbul Faculty of Medicine, Istanbul-Turkey
3Department of Biochemistry, Istanbul University Institute of Oncology, Istanbul-Turkey
4Department of Gynecological Oncology, Istanbul University, Istanbul Faculty of Medicine, Istanbul-Turkey DOI : 10.5505/tjo.2021.2882 OBJECTIVE
The aim of the present study was to evaluate the impact of conventional hemogram parameters as a biomarker in epithelial ovarian cancer (EOC) patients; and the clinical importance of the difference after chemotherapy.
METHODS
We have evaluated the patients with advanced-stage EOC who diagnosed between January 2012 and
December 2017.
RESULTS
Elevated levels of neutrophils, neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio at the
time of diagnosis were significantly associated with excess amount of ascites. Lower levels of neutrophils
and hemoglobin (HGB); and higher levels of red cell distribution width (RDW), and RDW/HGB ratio
were predictors of platinum-sensitivity. In univariate analysis, while decreased mean platelet volume
(MPV) was associated with longer disease free survival (DFS); elevated RDW, decreased neutrophils,
MPV, and NLR were effective for better overall survival (OS). In multivariate analysis, platinum sensitivity
and MPV were significantly associated with DFS and OS. Importantly, patients with persistently low
MPV group after chemotherapy had the best OS; while persistently high MPV group had the worst OS.
CONCLUSION
MPV is a marker that can be easily evaluated during complete blood counts, and might be a promising
and practical prognostic biomarker in the field of EOC. Hemogram parameters are found useful to
predict disease properties and survival in EOC.